Will Life on Mars Require a Genetic Rewrite?
By Scott Solomon,
The MIT Press Reader
| 02. 12. 2026
Chris Mason is a man in a hurry.
“Sometimes walking from the subway to the lab takes too long, so I’ll start running,” he told me over breakfast at a bistro near his home in Brooklyn on a crisp autumn morning. “Just so I can get there faster. Not because I’m late for a meeting, just because it’s taking too long to walk…I’m the only one I know who runs to work to get there faster."
Mason is a professor of physiology and biophysics at Weill Cornell Medicine. At least that’s his official title. He seems to be working on a hundred different projects all at once, ranging from tracking changes in the virus that causes COVID-19 to helping corals adapt to climate change.
The previous day, I had visited his research group on the Upper East Side. The Mason Lab occupied four separate laboratories across three buildings and was still growing. Although they were pursuing a wide range of projects, a major focus of their work was on how the human genome and microbiome are affected by spaceflight...
Related Articles
By Marisa Flook , BioNews | 06.29.2026
An anti-ageing gene therapy not approved by the US Food and Drug Administration (FDA) is set to be offered by an American company at overseas clinics outside of US jurisdiction.
The treatment, developed by Minicircle from Austin, Texas, uses a...
By Philip Ball , Nature | 06.17.2026
Our genomes are full of mutations that have the potential to damage our health or even kill us. Yet most of them rarely cause problems. Why? It’s partly thanks to a family of proteins that mask, or ‘buffer’, the ill...
By Philip Ball, Quanta Magazine | 06.18.2026
Since its molecular structure was deduced in the 1950s, DNA has been hailed by many biologists as the secret of life. They’ve read and studied the information stored in the DNA found in the cells of living organisms, known as...
By Arche Noah, GMWatch | 06.17.2026
The European Parliament has voted for a wide-reaching deregulation of New Genomic Techniques (NGTs). There was no majority for amendments stopping patents on conventionally classically bred plants or NGT plants. “Today’s vote is a missed opportunity to protect Europe’s farmers...